New Biological Therapies for Low-Density Lipoprotein Cholesterol
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference126 articles.
1. Recent advances in developing PCSK9 inhibitors for lipid-lowering therapy;Lavecchia;Future Med Chem,2019
2. Cardiovascular event rates in statin-treated Korean patients with cardiovascular disease: estimates from a real-world population using electronic medical record data;Kwon;Cardiovasc Drugs Ther,2023
3. Characterization of autosomal dominant hypercholesterolemia caused by PCSK9 gain of function mutations and its specific treatment with alirocumab, a PCSK9 monoclonal antibody;Hopkins;Circ Cardiovasc Genet,2015
4. PCSK9R46L, low-density lipoprotein cholesterol levels, and risk of ischemic heart disease;Benn;J Am Coll Cardiol,2010
5. Longitudinal association of PCSK9 sequence variations with low-density lipoprotein cholesterol levels: the Coronary Artery Risk Development in Young Adults Study;Huang;Circ Cardiovasc Genet,2009
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Drug interactions in cardiology: focus on statins and their combination with other lipid-lowering drugs;Expert Opinion on Drug Metabolism & Toxicology;2024-09-13
2. Angiopoietin-like Proteins and Lipoprotein Lipase: The Waltz Partners That Govern Triglyceride-Rich Lipoprotein Metabolism? Impact on Atherogenesis, Dietary Interventions, and Emerging Therapies;Journal of Clinical Medicine;2024-09-04
3. The Continuing Scourge of Atherosclerotic Cardiovascular Disease: Importance of Multidisciplinary and Innovative Person-Centred Approaches;Canadian Journal of Cardiology;2024-08
4. Medications for Lipid Control: Statins vs Newer Drugs;Canadian Journal of Cardiology;2024-08
5. Adverse Reactions to Evolocumab: Analysis of Real-World Data from EudraVigilance;Pharmaceuticals;2024-03-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3